Alzheon's Series A Round

Alzheon raised a round of funding on April 08, 2015. Investors include Ally Bridge Group.

Alzheon is a clinical-stage biotechnology company focused on developing first-in-class therapeutic platforms for both disease modification and symptomatic relief of Alzheimer's disease. The company is…

Articles about Alzheon's Series A Round: